Showing 1011-1020 of 1576 results for "".
- BlephEx Asserts Claims of Patent Infringement and False Advertising Against Myco Industrieshttps://modernod.com/news/blephex-asserts-claims-of-patent-infringement-and-false-advertising-against-myco-industries/2476700/BlephEx, creator of the BlephEx device and eyelid cleaning procedure, announced that it has asserted claims of willful patent infringement and false advertising against Myco Industries and John R
- Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in MGDhttps://modernod.com/news/azura-ophthalmics-presents-positive-results-from-phase-2b-clinical-trial-of-azr-md-001-in-meibomian-gland-dysfunction/2481286/Azura Ophthalmics announced that positive 3-month efficacy and safety results from its
- Eyewire News Exclusive: Q&A With Anne Coleman, MD, PhD, President of AAOhttps://modernod.com/news/eyewire-news-exclusive-qa-with-anne-coleman-md-phd-president-of-aao/2477474/The American Academy of Ophthalmology (AAO) continues to update its guidance for ophthalmologists dealing with the COVID-19 pandemic. Most recently, AAO updated its guidance on vaccine and t
- CMS Finalizes Plan to Allow Medicare Advantage Plans to Expand Telehealth Benefitshttps://modernod.com/news/cms-finalizes-plan-to-allow-medicare-advantage-plans-to-expand-telehealth-benefits/2477820/The Trump administration has finalized several changes in Medicare Advantage (MA) and Part D in anticipation of bid submissions on June 1, according to a FierceHealthcare
- Ocular Therapeutix Announces Board of Directors and Leadership Updateshttps://modernod.com/news/ocular-therapeutix-announces-board-of-directors-and-leadership-updates/2482128/Ocular Therapeutix announced Board of Directors and leadership updates with the addition of Pravin U. Dugel, MD as Executive Chairman; and the additions of Jeffrey S. Heier, MD, Peter K. Kaiser, MD, and Sanjay Nayak, MBBS, PhD, to the Ocular management
- New Book Now Available: "Cataract Surgery: Advanced Techniques for Complex and Complicated Cases"https://modernod.com/news/new-book-now-available-cataract-surgery-advanced-techniques-for-complex-and-complicated-cases/2481018/Renowned ophthalmologists Jorge Alio, MD, PhD, FEBOphth; Buchard Dick, MD, PhD, FEBOS-CR; and Bob Osher, MD, have edited a new book titled "Cataract Surgery in Complex and Complicated Cases." It includes a large number of videos that aims to enrich the didactic value
- Experts Provide Update on Medicare Waivers and Other Regulatory Provisions During COVID-19https://modernod.com/news/experts-provide-update-on-medicare-waivers-and-other-regulatory-provisions-during-covid-19/2479527/In a recent episode of Ophthalmology Off the Grid, cohosts Gary Wörtz, MD, and Blake Williamson, MD, MPH, spoke with Allison Shuren, JD, MSN; Paul Rudolf, MD, JD; and Thomas Gustafson, PhD, to discuss a variety of regulatory topic
- New App Allows Surgeons to Search for FDA Approved IOLshttps://modernod.com/news/new-app-allows-surgeons-to-search-for-fda-approved-iols/2480969/Matt Hirabayashi, MD, of eyeflymd.com, and Gurpal Virdi, MD, of Eyelabs.ai, have developed an app called “eyeSpace,” which is designed to allow surgeons and trainees to
- Hanita Lenses Launches Joint Venture with Ophthalmic Vision Care in the Iberian Peninsulahttps://modernod.com/news/hanita-lenses-launches-joint-venture-with-ophthalmic-vision-care-in-the-iberian-peninsula/2480732/Hanita Lenses announced a new joint venture with Madrid, Spain-based Ophthalmic Vision Care (OVC), a distributor IOLs for Hanita Lenses in Spain since 2016. The joint venture, named "Hanita Iberica," merges the assets of OVC—as a service provider of d
- NIH Study: Experimental Drug May Help Treat Condition May Help Treat Diabetic Retinopathyhttps://modernod.com/news/nih-study-experimental-drug-may-help-treat-condition-may-help-treat-diabetic-retinopathy/2482805/A new National Institutes of Health (NIH)-funded study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an important boundary that regulates the flow of nu